SKY-SEQ

Welcome to the Brand page for “SKY-SEQ”, which is offered here for Research and development of pharmaceuticals, small molecule therapies for the alteration of rna splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases using integrated and high-throughput screening technologies coupled with next-generation sequencing;.

Its status is currently believed to be active. Its class is unavailable. “SKY-SEQ” is believed to be currently owned by “SKYHAWK THERAPEUTICS, INC.”